A pilus peptide vaccine for the prevention of gonorrhea - PubMed (original) (raw)

• PMID: 6187017

Review

A pilus peptide vaccine for the prevention of gonorrhea

G K Schoolnik et al. Prog Allergy. 1983.

No abstract available

PubMed Disclaimer

Similar articles

• Pilus vaccines.
  Tramont EC, Boslego JW. Tramont EC, et al. Vaccine. 1985 Mar;3(1):3-10. doi: 10.1016/0264-410x(85)90003-9. Vaccine. 1985. PMID: 2408396 Review.
• Human immunization with Pgh 3-2 gonococcal pilus results in cross-reactive antibody to the cyanogen bromide fragment-2 of pilin.
  Johnson SC, Chung RC, Deal CD, Boslego JW, Sadoff JC, Wood SW, Brinton CC Jr, Tramont EC. Johnson SC, et al. J Infect Dis. 1991 Jan;163(1):128-34. doi: 10.1093/infdis/163.1.128. J Infect Dis. 1991. PMID: 1701817 Clinical Trial.
• Genital antibody response to a parenteral gonococcal pilus vaccine.
  McChesney D, Tramont EC, Boslego JW, Ciak J, Sadoff J, Brinton CC. McChesney D, et al. Infect Immun. 1982 Jun;36(3):1006-12. doi: 10.1128/iai.36.3.1006-1012.1982. Infect Immun. 1982. PMID: 6124502 Free PMC article.
• Efficacy trial of a parenteral gonococcal pilus vaccine in men.
  Boslego JW, Tramont EC, Chung RC, McChesney DG, Ciak J, Sadoff JC, Piziak MV, Brown JD, Brinton CC Jr, Wood SW, et al. Boslego JW, et al. Vaccine. 1991 Mar;9(3):154-62. doi: 10.1016/0264-410x(91)90147-x. Vaccine. 1991. PMID: 1675029 Clinical Trial.
• New concepts in vaccines for mucosal non-enteric human bacterial pathogens.
  Westerink MA, Campagnari AA, Nelson MB, Murphy TF, Apicella MA. Westerink MA, et al. Adv Exp Med Biol. 1989;251:17-31. doi: 10.1007/978-1-4757-2046-4_3. Adv Exp Med Biol. 1989. PMID: 2481958 Review. No abstract available.

Cited by

• Neisseria gonorrhoeae vaccines: a contemporary overview.
  Williams E, Seib KL, Fairley CK, Pollock GL, Hocking JS, McCarthy JS, Williamson DA. Williams E, et al. Clin Microbiol Rev. 2024 Mar 14;37(1):e0009423. doi: 10.1128/cmr.00094-23. Epub 2024 Jan 16. Clin Microbiol Rev. 2024. PMID: 38226640 Review.
• Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development.
  Edwards JL, Jennings MP, Apicella MA, Seib KL. Edwards JL, et al. Crit Rev Microbiol. 2016 Nov;42(6):928-41. doi: 10.3109/1040841X.2015.1105782. Epub 2016 Jan 23. Crit Rev Microbiol. 2016. PMID: 26805040 Free PMC article. Review.
• Epitope mapping immunodominant regions of the PilA protein of nontypeable Haemophilus influenzae (NTHI) to facilitate the design of two novel chimeric vaccine candidates.
  Novotny LA, Adams LD, Kang DR, Wiet GJ, Cai X, Sethi S, Murphy TF, Bakaletz LO. Novotny LA, et al. Vaccine. 2009 Dec 10;28(1):279-89. doi: 10.1016/j.vaccine.2009.08.017. Epub 2009 Aug 22. Vaccine. 2009. PMID: 19699813 Free PMC article.
• Assembly and antigenicity of the Neisseria gonorrhoeae pilus mapped with antibodies.
  Forest KT, Bernstein SL, Getzoff ED, So M, Tribbick G, Geysen HM, Deal CD, Tainer JA. Forest KT, et al. Infect Immun. 1996 Feb;64(2):644-52. doi: 10.1128/iai.64.2.644-652.1996. Infect Immun. 1996. PMID: 8550220 Free PMC article.
• Type IV prepilin peptidase gene of Neisseria gonorrhoeae MS11: presence of a related gene in other piliated and nonpiliated Neisseria strains.
  Dupuy B, Pugsley AP. Dupuy B, et al. J Bacteriol. 1994 Mar;176(5):1323-31. doi: 10.1128/jb.176.5.1323-1331.1994. J Bacteriol. 1994. PMID: 7906688 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information